Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potential can be a tough task.In addition to volatility, these stocks carry above-average risk by their very nature. Also, one could end up losing from a stock whose growth story is actually over or nearing its end.However, the Zacks Growth Style Score (part of the Zacks Style S ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? The Zacks ...

Westlake, Ohio-based Nordson Corporation (NDSN) engineers, manufactures, and markets products and systems to dispense, apply, and control adhesives, coatings, polymers, sealants, biomaterials, and other fluids. Valued at $16.2 billion by market cap, the company's products include customized electronic controls for the precise application and curing of materials to meet customers' requirements. Shares of this precision technology company have outperformed the broader market over the past year. NDSN has ga ...

Financial Performance - Consolidated sales for the three months ended January 31, 2026, were $669,461,000, representing an 8.8% increase from $615,420,000 in the same period of 2025 [82]. - Gross margin improved slightly to 54.7% for the three months ended January 31, 2026, compared to 54.6% in the prior year [85]. - Net income increased by 40.9% to $133,382,000, or $2.38 per diluted share, up from $94,652,000, or $1.65 per diluted share, in the same period of 2025 [90]. - Operating profit rose by 18.1% to $166,405,000 for the three months ended January 31, 2026, compared to $140,947,000 in the prior year [82]. - Segment EBITDA for the Medical and Fluid Solutions segment increased by 3.1% to $70,206,000, driven by favorable mix and strong organic sales growth [86]. Regional Performance - The Asia Pacific region saw a significant organic sales increase of 23.2%, contributing to total sales growth [84]. Cash Flow and Liquidity - Cash and cash equivalents increased by $11,950,000 during the three months ended January 31, 2026 [91]. - The company maintained a strong liquidity position with $120,392,000 in cash on hand and $945,420,000 in available borrowings as of January 31, 2026 [94]. - The company repurchased $86,001,000 in common shares and paid $45,786,000 in dividends during the same period [91]. - Interest expense decreased to $22,741,000 for the three months ended January 31, 2026, down from $25,618,000 in the comparable period of 2025 [88]. Forward-Looking Statements - The company acknowledges the presence of forward-looking statements that may involve risks and uncertainties, including economic and political conditions, market conditions, and potential acquisitions [95]. - Actual results may differ significantly from expected results due to various factors, and readers are cautioned against placing undue reliance on forward-looking statements [96]. - The company has disclosed information regarding financial instruments sensitive to interest rates and foreign currency exchange rates, which has not changed materially since the last report [98].

Key Takeaways Nordson's Q1 fiscal 2026 EPS rose 15% to $2.37, beating estimates as revenues grew 8.8% year over year.NDSN's Advanced Technology Solutions sales jumped 23.1%, with organic growth of 20.7% in the quarter.Nordson raised fiscal 2026 guidance, projecting sales of $2.86-$2.96B and EPS of $11-$11.60.Nordson Corporation’s (NDSN) first-quarter fiscal 2026 (ended Jan. 31, 2026) adjusted earnings of $2.37 per share surpassed the Zacks Consensus Estimate of $2.36. The bottom line increased 15% year over ...

Adjusted operating profit increased 10% year-over-year to $166 million. EBITDA rose 8% to a first-quarter record $203 million, and EBITDA margin was 30%, in line with the prior year. Hopgood said margins were influenced by the geographic and product mix of sales growth, noting that growth was concentrated in Asia where gross margins are generally lower, particularly on system sales, resulting in lower incremental margins that management expects to normalize over time.Executive Vice President and CFO Daniel ...

Nordson (NasdaqGS:NDSN) Q1 2026 Earnings call February 19, 2026 08:30 AM ET Company ParticipantsDaniel Hopgood - EVP and CFOLara Mahoney - VP of Investor Relations and Corporate CommunicationsSundaram Nagarajan - President and CEOConference Call ParticipantsAndrew Buscaglia - AnalystBrad Hewitt - AnalystChris Dankert - AnalystChristopher Glynn - AnalystJeff Hammond - AnalystMatt Summerville - AnalystMike Halloran - AnalystRobert Jamieson - AnalystWalter Liptak - AnalystOperatorHello, everyone. Thank you for ...

Financial Data and Key Metrics Changes - The company achieved record first-quarter sales of $669 million, a 9% increase from $615 million in the prior year, with 7% organic growth [5][8] - Adjusted operating profit rose 10% year-over-year to $166 million, while EBITDA increased by 8% to $203 million, maintaining an EBITDA margin of 30% [9][6] - Free cash flow was $123 million, with a cash flow conversion rate exceeding 100% of net income [7][17] Business Line Data and Key Metrics Changes - **Industrial Precision Solutions (IPS)**: Sales of $327 million, a 9% increase year-over-year, with organic sales up 3% [12] - **Medical and Fluid Solutions (MFS)**: Sales of $193 million, relatively flat compared to the prior year, with organic sales up 3% [13][14] - **Advanced Technology Solutions (ATS)**: Sales increased by 23% to $149 million, with a 21% organic sales increase driven by semiconductor applications [16] Market Data and Key Metrics Changes - Strong demand was noted in Asia across most end markets, particularly in the semiconductor space, contributing to overall organic growth [8][12] - The company reported a favorable currency translation impact of 4% on sales, although this was partially offset by a divestiture [8][9] Company Strategy and Development Direction - The company is focused on maintaining strong EBITDA margins while strategically deploying capital for growth and shareholder returns [18][19] - Investments in semiconductor applications are a key growth driver, with a focus on advanced packaging processes and quality control technologies [21][22] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about end market demand trends and noted that while market conditions have improved, vigilance is required for potential downturns [20][24] - The company increased its full-year sales guidance to a range of $2.86 billion to $2.98 billion, reflecting a 4.5% increase at the midpoint [24][25] Other Important Information - The company repurchased $82 million in shares and paid $46 million in dividends during the quarter [18] - The balance sheet remains strong, with a leverage ratio of 2.1 times, allowing for continued strategic capital deployment [17] Q&A Session Summary Question: Can you unpack the margin dynamics around systems and geographic mix? - Management indicated that the primary segment facing mix challenges was IPS, but there has been no fundamental change in the margin outlook [30][31] Question: Can you expand on the slow start in medical and the weather impact? - The weather-related impact was estimated at about 1%, with underlying demand remaining strong and a return to mid-single-digit growth expected [36][38] Question: What are the moving pieces in the ATS segment? - Strong momentum was noted in dispense businesses, with X-ray business starting to recover, and overall confidence in ATS segment growth [46][48] Question: How does FX impact margins across segments? - FX had a positive impact on IPS sales, but the incremental benefit was lower, contributing to performance challenges [79][83] Question: What end markets are expected to outperform base case estimates? - Potential upside is anticipated from further inflection in general industrial and automotive demand, as well as ongoing strength in ATS [92][90]

Nordson (NasdaqGS:NDSN) Q1 2026 Earnings call February 19, 2026 08:30 AM ET Speaker9Hello, everyone. Thank you for joining us, and welcome to the Nordson Corporation First Quarter Fiscal Year 2026 conference call. After today's prepared remarks, we will host a question and answer session. If you would like to ask a question, please press star one on your telephone keypad. To withdraw your question, press star one again. I will now hand the call over to Lara Mahoney. Please go ahead.Speaker6Thank you. Good m ...

Under the Private Securities Litigation Reform Act of 1995 Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by terminology such as "may," "will," "should," "could," "expects," "anticipates," "believes," "projects," "forecasts," "outlook," "guidance," "continue," "target," or the negative of these terms or comparable terminology. These statements reflect manageme ...